In search of targeted therapies for childhood cancer

Frontiers in Oncology

Volumn 1, Issue JUL, 2011, Pages

  Mackall, Crystal L ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84880203379     PISSN: None     EISSN: 2234943X     Source Type: Journal    
DOI: 10.3389/fonc.2011.00018     Document Type: Article

References (47)

1. Adamson, P. C., Weiner, S. L., Simone, J. V., and Gelband, H. (2005). Making Better Drugs for Children with Cancer. Washington, DC: National Academies Press.
2. Aldrich, M. C., Zhang, L., Wiemels, J. L., Ma, X., Loh, M. L., Metayer, C., Selvin, S., Feusner, J., Smith, M. T., and Buffler, P. A. (2006). Cytogenetics of Hispanic and White children with acute lymphoblastic leukemia in California. Cancer Epidemiol. Biomarkers Prev. 15, 578-581.
3. Angiolillo, A. L., Yu, A. L., Reaman, G., Ingle, A. M., Secola, R., and Adamson, P. C. (2009). A phase II study of Campath-1H in children with relapsed or refractory acute lymphoblastic leukemia: a Children's Oncology Group report. Pediatr. Blood Cancer 53, 978-983.
4. Attias, D., and Weitzman, S. (2008). The efficacy of rituximab in high-grade pediatric B-cell lymphoma/leukemia: a review of available evidence. Curr. Opin. Pediatr. 20, 17-22.
5. Bercovich, D., Ganmore, I., Scott, L. M., Wainreb, G., Birger, Y., Elimelech, A., Shochat, C., Cazzaniga, G., Biondi, A., Basso, G., Cario, G., Schrappe, M., Stanulla, M., Strehl, S., Haas, O. A., Mann, G., Binder, V., Borkhardt, A., Kempski, H., Trka, J., Bielorei, B., Avigad, S., Stark, B., Smith, O., Dastugue, N., Bourquin, J. P., Tal, N. B., Green, A. R., and Izraeli, S. (2008). Mutations of JAK2 in acute lymphoblastic leukaemias associated with Down's syndrome. Lancet 372, 1484-1492.
6. Bhatia, S. (2011). Disparities in cancer outcomes: lessons learned from children with cancer. Pediatr. Blood Cancer 56, 994-1002.
7. Bhatia, S., Sather, H. N., Heerema, N. A., Trigg, M. E., Gaynon, P. S., and Robison, L. L. (2002). Racial and ethnic differences in survival of children with acute lymphoblastic leukemia. Blood 100, 1957-1964.
8. Children's Oncology Group, Aplenc, R., Alonzo, T. A., Gerbing, R. B., Smith, F. O., Meshinchi, S., Ross, J. A., Perentesis, J., Woods, W. G., Lange, B. J., and Davies, S. M. (2006). Ethnicity and survival in childhood acute myeloid leukemia: a report from the Children's Oncology Group. Blood 108, 74-80.
9. Dougherty, M. J., Santi, M., Brose, M. S., Ma, C., Resnick, A. C., Sievert, A. J., Storm, P. B., and Biegel, J. A. (2010). Activating mutations in BRAF characterize a spectrum of pediatric low-grade gliomas. Neuro Oncol. 12, 621-630.
10. DuBois, S. G., and Grier, H. E. (2009). Chemotherapy: the role of ifosfamide and etoposide in Ewing sarcoma. Nat. Rev. Clin. Oncol. 6, 251-253.
11. Fox, E., Widemann, B. C., Whitcomb, P. O., Aikin, A., Dombi, E., Lodish, M., Stratakis, C. A., Steinberg, S., Wells, S. A., and Balis, F. M. Jr. (2009). Phase I/II Trial of Vandetanib in Children and Adolescents With Hereditary Medullary Thyroid Carcinoma. Orlando, FL: American Society of Clinical Oncology, 15s.
12. Gaikwad, A., Rye, C. L., Devidas, M., Heerema, N. A., Carroll, A. J., Izraeli, S., Plon, S. E., Basso, G., Pession, A., and Rabin, K. R. (2009). Prevalence and clinical correlates of JAK2 mutations in down syndrome acute lymphoblastic leukaemia. Br. J. Haematol. 144, 930-932.
13. Gambacorti-Passerini, C., Messa, C., and Pogliani, E. M. (2011). Crizotinib in anaplastic large-cell lymphoma. N. Engl. J. Med. 364, 775-756.
14. Geenen, M. M., Cardous-Ubbink, M. C., Kremer, L. C., van den Bos, C., van der Pal, H. J., Heinen, R. C., Jaspers, M. W., Koning, C. C., Oldenburger, F., Langeveld, N. E., Hart, A. A., Bakker, P. J., Caron, H. N., and van Leeuwen, F. E. (2007). Medical assessment of adverse health outcomes in long-term survivors of childhood cancer. JAMA 297, 2705-2715.
15. Hargrave, D., Bartels, U., and Bouffet, E. (2006). Diffuse brainstem glioma in children: critical review of clinical trials. Lancet Oncol. 7, 241-248.
16. Harvey, R. C., Mullighan, C. G., Wang, X., Dobbin, K. K., Davidson, G. S., Bedrick, E. J., Chen, I. M., Atlas, S. R., Kang, H., Ar, K., Wilson, C. S., Wharton, W., Murphy, M., Devidas, M., Carroll, A. J., Borowitz, M. J., Bowman, W. P., Downing, J. R., Relling, M., Yang, J., Bhojwani, D., Carroll, W. L., Camitta, B., Reaman, G. H., Smith, M., Hunger, S. P., and Willman, C. L. (2010). Identification of novel cluster groups in pediatric high-risk B-precursor acute lymphoblastic leukemia with gene expression profiling: correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcome. Blood 116, 4874-4884.
17. Hoffmann, K. M., Moser, A., Lohse, P., Winkler, A., Binder, B., Sovinz, P., Lackner, H., Schwinger, W., Benesch, M., and Urban, C. (2008). Successful treatment of progressive cutaneous mastocytosis with imatinib in a 2-year-old boy carrying a somatic KIT mutation. Blood 112, 1655-1657.
18. Hon, Y. Y., Fessing, M. Y., Pui, C. H., Relling, M. V., Krynetski, E. Y., and Evans, W. E. (1999). Polymorphism of the thiopurine S-methyltransferase gene in African-Americans. Hum. Mol. Genet. 8, 371-376.
19. Janeway, K. A., Kim, S. Y., Lodish, M., Nosé, V., Rustin, P., Gaal, J., Dahia, P. L., Liegl, B., Ball, E. R., Raygada, M., Lai, A. H., Kelly, L., Hornick, J. L., NIH Pediatric and Wild-Type GIST Clinic, O'Sullivan, M., de Krijger, R. R., Dinjens, W. N., Demetri, G. D., Antonescu, C. R., Fletcher, J. A., Helman, L., and Stratakis, C. A. (2011). Defects in succinate dehydrogenase in gastrointestinal stromal tumors lacking KIT and PDGFRA mutations. Proc. Natl. Acad. Sci. U.S.A. 108, 314-318.
20. Janoueix-Lerosey, I., Lequin, D., Brugieres, L., Ribeiro, A., de Pontual, L., Combaret, V., Raynal, V., Puisieux, A., Schleiermacher, G., Pierron, G., Valteau-Couanet, D., Frebourg, T., Michon, J., Lyonnet, S., Amiel, J., and Delattre, O. (2008). Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma. Nature 455, 967-970.
21. Ladenstein, R., Potschger, U., Le Deley, M. C., Whelan, J., Paulussen, M., Oberlin, O., van den Berg, H., Dirksen, U., Hjorth, L., Michon, J., Lewis, I., Craft, A., and Jürgens, H. (2010). Primary disseminated multifocal Ewing sarcoma: results of the Euro-EWING 99 trial. J. Clin. Oncol. 28, 3284-3291.
22. Lange, B. J., Smith, F. O., Feusner, J., Barnard, D. R., Dinndorf, P., Feig, S., Heerema, N. A., Arndt, C., Arceci, R. J., Seibel, N., Weiman, M., Dusenbery, K., Shannon, K., Luna-Fineman, S., Gerbing, R. B., and Alonzo, T. A. (2008). Outcomes in CCG-2961, a children's oncology group phase 3 trial for untreated pediatric acute myeloid leukemia: a report from the Children's Oncology Group. Blood 111, 1044-1053.
23. Levis, M., Ravandi, F., Wang, E. S., Baer, M. R., Perl, A., Coutre, S., Erba, H., Stuart, R. K., Baccarani, M., Cripe, L. D., Tallman, M. S., Meloni, G., Godley, L. A., Langston, A. A., Amadori, S., Lewis, I. D., Nagler, A., Stone, R., Yee, K., Advani, A., Douer, D., Wiktor-Jedrzejczak, W., Juliusson, G., Litzow, M. R., Petersdorf, S., Sanz, M., Kantarjian, H. M., Sato, T., Tremmel, L., Bensen-Kennedy, D. M., Small, D., and Smith, B. D. (2011). Results from a randomized trial of salvage chemotherapy followed by lestaurtinib for patients with FLT3 mutant AML in first relapse. Blood 117, 3294-3301.
24. Maki, R. G. (2008). Pediatric sarcomas occurring in adults. J. Surg. Oncol. 97, 360-368.
25. Margolin, J. F., Rabin, K. R., Steuber, C. P., and Poplack, D. G. (2011). "Acute lymphoblastic leukemia," in Principles and Practice of Pediatric Oncology, 6th Edn, eds P. A. Pizzo and D. G. Poplack (Philadelphia, PA: Lippincott Williams & Wilkins), 518-566.
26. Meinhardt, A., Burkhardt, B., Zimmermann, M., Borkhardt, A., Kontny, U., Klingebiel, T., Berthold, F., Janka-Schaub, G., Klein, C., Kabickova, E., Klapper, W., Attarbaschi, A., Schrappe, M., Reiter, A., and Berlin-Frankfurt-Münster group. (2010). Phase II window study on rituximab in newly diagnosed pediatric mature B-cell non-Hodgkin's lymphoma and Burkitt leukemia. J. Clin. Oncol. 28, 3115-3121.
27. Millot, F., Guilhot, J., Nelken, B., Leblanc, T., De Bont, E. S., Békassy, A. N., Gadner, H., Sufliarska, S., Stary, J., Gschaidmeier, H., Guilhot, F., and Suttorp, M. (2006). Imatinib mesylate is effective in children with chronic myelogenous leukemia in late chronic and advanced phase and in relapse after stem cell transplantation. Leukemia 20, 187-192.
28. Mosse, Y. P., Laudenslager, M., Longo, L., Cole, K. A., Wood, A., Attiyeh, E. F., Laquaglia, M. J., Sennett, R., Lynch, J. E., Perri, P., Laureys, G., Speleman, F., Kim, C., Hou, C., Hakonarson, H., Torkamani, A., Schork, N. J., Brodeur, G. M., Tonini, G. P., Rappaport, E., Devoto, M., and Maris, J. M. (2008). Identification of ALK as a major familial neuroblastoma predisposition gene. Nature 455, 930-935.
29. Mullighan, C. G., Zhang, J., Harvey, R. C., Collins-Underwood, J. R., Schulman, B. A., Phillips, L. A., Tasian, S. K., Loh, M. L., Su, X., Liu, W., Devidas, M., Atlas, S. R., Chen, I. M., Clifford, R. J., Gerhard, D. S., Carroll, W. L., Reaman, G. H., Smith, M., Downing, J. R., Hunger, S. P., and Willman, C. L. (2009). JAK mutations in high-risk childhood acute lymphoblastic leukemia. Proc. Natl. Acad. Sci. U.S.A. 106, 9414-9418.
30. Oeffinger, K. C., Mertens, A. C., Sklar, C. A., Kawashima, T., Hudson, M. M., Meadows, A. T., Friedman, D. L., Marina, N., Hobbie, W., Kadan-Lottick, N. S., Schwartz, C. L., Leisenring, W., Robison, L. L., and Childhood Cancer Survivor Study. (2006). Chronic health conditions in adult survivors of childhood cancer. N. Engl. J. Med. 355, 1572-1582.
31. Pappo, A. S., and Janeway, K. A. (2009). Pediatric gastrointestinal stromal tumors. Hematol. Oncol. Clin. North Am. 23, 15-34.
32. Passoni, L., Longo, L., Collini, P., Coluccia, A. M., Bozzi, F., Podda, M., Gregorio, A., Gambini, C., Garaventa, A., Pistoia, V., Del Grosso, F., Tonini, G. P., Cheng, M., Gambacorti-Passerini, C., Anichini, A., Fossati-Bellani, F., Di Nicola, M., and Luksch, R. (2009). Mutation-independent anaplastic lymphoma kinase overexpression in poor prognosis neuroblastoma patients. Cancer Res. 69, 7338-7346.
33. Patel, S., Pappo, A. S., Crowley, J., Reinke, D., Eid, J., Ritland, S., Chawla, S., Staddon, A., Maki, R., Vassal, G., and Helman, L. (2009). A SARC Global Collaborative Phase II Trial of R1507, a Recombinant Human Monoclonal Antibody to the Insulin-Like Growth Factor-1 Receptor (IGF1R) in Patients With Recurrent or Refractory Sarcomas. Orlando, FL: American Society of Clinical Oncology. [Abstract #10503].
34. Percy, C. L., Smith, M. A., Linet, M., Gloeckler, R., and Friedman, D. L. (1999). "Lymphomas and reticuloendothelial neoplasms," in Cancer Incidence and Survival Among Children and Adolescents: United States SEER Program 1975-1995, eds L. A. G. Ries, M. A. Smith, J. G. Gurney, M. Linet, T. Tamra, J. L. Young, and G. R. Bunin (Bethesda, MD: National Cancer Institute, SEER Program), 35-50.
35. Perez, E. A., Kassira, N., Cheung, M. C., Koniaris, L. G., Neville, H. L., and Sola, J. E. (2011). Rhabdomyosarcoma in children: a SEER population based study. J. Surg. Res. doi: 10.1016/j.jss.2011.03.001. [Epub ahead of print].
36. Pieters, R. (2009). Infant acute lymphoblastic leukemia: lessons learned and future directions. Curr. Hematol. Malig. Rep. 4, 167-174.
37. Pollock, B. H., DeBaun, M. R., Camitta, B. M., Shuster, J. J., Ravindranath, Y., Pullen, D. J., Land, V. J., Mahoney, D. H. Jr., Lauer, S. J., and Murphy, S. B. (2000). Racial differences in the survival of childhood B-precursor acute lymphoblastic leukemia: a Pediatric Oncology Group Study. J. Clin. Oncol. 18, 813-823.
38. Poulikakos, P. I., and Rosen, N. (2011). Mutant BRAF melanomas-dependence and resistance. Cancer Cell 19, 11-15.
39. Price, V. E., Fletcher, J. A., Zielenska, M., Cole, W., Viero, S., Manson, D. E., Stuart, M., and Pappo, A. S. (2005). Imatinib mesylate: an attractive alternative in young children with large, surgically challenging dermatofibrosarcoma protuberans. Pediatr. Blood Cancer 44, 511-515.
40. Quintas-Cardama, A., Kantarjian, H., Cortes, J., and Verstovsek, S. (2011). Janus kinase inhibitors for the treatment of myeloproliferative neoplasias and beyond. Nat. Rev. Drug Discov. 10, 127-140.
41. Raney, R. B., Anderson, J. R., Barr, F. G., Donaldson, S. S., Pappo, A. S., Qualman, S. J., Wiener, E. S., Maurer, H. M., and Crist, W. M. (2001). Rhabdomyosarcoma and undifferentiated sarcoma in the first two decades of life: a selective review of intergroup rhabdomyosarcoma study group experience and rationale for Intergroup Rhabdomyosarcoma Study V. J. Pediatr. Hematol. Oncol. 23, 215-220.
42. Reiter, A., Meinhardt, A., Burkhardt, B., Zimmermann, M., Borkhardt, A., Kontny, U., Mann, G., and Schrappe, M. (2009). Phase II Window Study on Rituximab in Newly Diagnosed Pediatric Mature B-Cell Non-Hodkin Lymphoma (NHL). Orlando, FL: American Society of Clinical Oncology, 15s. [abstr 10000].
43. Scheurer, M. E., Bondy, M. L., and Gurney, J. G. (2011). "Epidemiology of childhood cancer," in Principles and Practice of Pediatric Oncology, 6th Edn, eds P. A. Pizzo and D. G. Poplack (Philadelphia, PA: Lippincott Williams & Wilkins, A Wolters Kluwer Business), 2-16.
44. Schindler, G., Capper, D., Meyer, J., Janzarik, W., Omran, H., Herold-Mende, C., Schmieder, K., Wesseling, P., Mawrin, C., Hasselblatt, M., Louis, D. N., Korshunov, A., Pfister, S., Hartmann, C., Paulus, W., Reifenberger, G., and von Deimling, A. (2011). Analysis of BRAF V600E mutation in 1, 320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma. Acta Neuropathol. 121, 397-405.
45. Schultz, K. R., Bowman, W. P., Aledo, A., Slayton, W. B., Sather, H., Devidas, M., Wang, C., Davies, S. M., Gaynon, P. S., Trigg, M., Rutledge, R., Burden, L., Jorstad, D., Carroll, A., Heerema, N. A., Winick, N., Borowitz, M. J., Hunger, S. P., Carroll, W. L., and Camitta, B. (2009). Improved early event-free survival with imatinib in Philadelphia chromosome-positive acute lymphoblastic leukemia: a Children's Oncology Group Study. J. Clin. Oncol. 27, 5175-5181.
46. Tricoli, J. V., Seibel, N. L., Blair, D. G., Albritton, K., and Hayes-Lattin, B. (2011). Unique characteristics of adolescent and young adult acute lymphoblastic leukemia, breast cancer, and colon cancer. J. Natl. Cancer Inst. 103, 628-635.
47. Yu, A. L., Gilman, A. L., Ozkaynak, M. F., London, W. B., Kreissman, S. G., Chen, H. X., Smith, M., Anderson, B., Villablanca, J. G., Matthay, K. K., Shimada, H., Grupp, S. A., Seeger, R., Reynolds, C. P., Buxton, A., Reisfeld, R. A., Gillies, S. D., Cohn, S. L., Maris, J. M., Sondel, P. M., and Children's Oncology Group. (2010). Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma. N. Engl. J. Med. 363, 1324-1334.